Manila Times Business
Abaxx Announces Filing of Prospectus Supplement in Connection with Previously Announced Bought Deal Offering
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES/ TORONTO and SINGAPORE, May 28, 2026 (GLOBE NEWSWIRE) -- Abaxx Technologies Inc. ("Abaxx" or the "Company") (TSX : ABXX) (OTCQX : ABXXF) is pleased to announce that it has filed a prospectus supplement dated May 28, 2026 (the "Prospectus Supplement”) to its short form base shelf prospectus dated May 8, 2026 (the "Bas
This is an excerpt. Read the full article at the original source:
Source: manilatimes.net
Read Full Article on manilatimes.net →More from Manila Times Business
Mineralys Therapeutics Presents New Data from the Phase 3 Launch-HTN Trial of Lorundrostat in Participants with Hypertension and Chronic Kidney Disease at European Meeting on Hypertension and Cardiovascular Protection (ESH 2026)
1h ago
Ghana's 'anti-LGBTQ' law triggers both praise and outrage
2h ago
WHO chief visits epicentre of Ebola outbreak in DR Congo
2h ago
Vapofil Reviews [URGENT REPORT 2026] The Shocking VapoFil Male Enhancement Supplement Trend Everyone Is Talking About
2h ago